'Monopoly' Concerns Over Patents for J. Craig Venter Institute's Synthetic Cell Technology (update)

Patents pending that relate to techniques for generating synthetic cells could provide the J. Craig Venter Institute (JCVI; San Diego, CA) with a “monopoly” position on a range of genetic engineering activities, says professor John Sulston, chair of the Institute for Science, Ethics and Innovation (iSEI) at the University of Manchester (Manchester, U.K.).   The comments by Sulston, a Nobel prize winner in the field of molecular biology, follow the announcement made in the past week by JCVI that it has become the first company to...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers